Key facts
- It has raised $2.6M; the latest was Later Stage VC in Jul 2025.
- Notable investors include Impact Assets, Innovation Authority, Nova Capital (Italy), Jack Herrick, Annie Chrien — 30 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 30 names
- ·Watchlist + deal alerts for Magentiq Eye
- ·The full record, as it builds
Funding rounds
No funding rounds for Magentiq Eye are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Magentiq Eye
Developer of an artificial intelligence-based medical device designed to aid physicians when performing endoscopic medical procedures. The company's devices apply deep learning, computer vision, and video analysis technologies that feature the ability of automatic polyp detection during colonoscopy to decide the further course of action during the examination, enabling doctors to perform better medical exams and procedures and cure patients worldwide.
- Sector
- Healthcare
- HQ
- Haifa, Israel
- Founded
- 2014
- Employees
- 22
- Website
- magentiq.com/
- Ownership
- Privately Held (backing)
Magentiq Eye doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Magentiq Eye shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Magentiq Eye in its N-PORT filings yet. We sweep new filings monthly.